Mogy Joel R Investment Counsel’s AbbVie ABBV Stock Holding History

Mogy Joel R Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5M	Sell	41,919 -1,125	-3%	-$242K	0.6%	27
2026 Q1	$9.36M	Sell	43,044 -2,510	-6%	-$557K	0.59%	29
2025 Q4	$10.4M	Sell	45,554 -207	-0.5%	-$47.2K	0.56%	30
2025 Q3	$10.6M	Hold	45,761	–	–	0.58%	29
2025 Q2	$8.49M	Hold	45,761	–	–	0.49%	32
2025 Q1	$9.59M	Sell	45,761 -6,632	-13%	-$1.29M	0.62%	31
2024 Q4	$9.31M	Buy	52,393 +32	+0.1%	+$5.88K	0.55%	35
2024 Q3	$10.3M	Hold	52,361	–	–	0.63%	34
2024 Q2	$8.98M	Hold	52,361	–	–	0.57%	34
2024 Q1	$9.53M	Sell	52,361 -200	-0.4%	-$34.5K	0.65%	32
2023 Q4	$8.15M	Sell	52,561 -2,040	-4%	-$297K	0.62%	36
2023 Q3	$8.14M	Sell	54,601 -8,375	-13%	-$1.23M	0.68%	35
2023 Q2	$8.48M	Hold	62,976	–	–	0.67%	34
2023 Q1	$10M	Sell	62,976 -20	-0%	-$3.06K	0.89%	32
2022 Q4	$10.2M	Buy	62,996 +350	+0.6%	+$53.7K	1.02%	33
2022 Q3	$8.41M	Sell	62,646 -21	-0%	-$3.01K	0.88%	32
2022 Q2	$9.6M	Buy	62,667 +21	+0%	+$3.21K	0.95%	32
2022 Q1	$10.2M	Sell	62,646 -402	-0.6%	-$58.4K	0.8%	34
2021 Q4	$8.54M	Buy	63,048 +20	+0%	+$2.36K	0.61%	36
2021 Q3	$6.8M	Hold	63,028	–	–	0.56%	36
2021 Q2	$7.1M	Sell	63,028 -30	-0%	-$3.38K	0.6%	35
2021 Q1	$6.82M	Hold	63,058	–	–	0.66%	35
2020 Q4	$6.76M	Sell	63,058 -400	-0.6%	-$38.4K	0.67%	35
2020 Q3	$5.56M	Sell	63,458 -300	-0.5%	-$28.2K	0.6%	36
2020 Q2	$6.26M	Hold	63,758	–	–	0.75%	33
2020 Q1	$4.86M	Sell	63,758 -300	-0.5%	-$25.6K	0.69%	35
2019 Q4	$5.67M	Sell	64,058 -10	-0%	-$830	0.68%	34
2019 Q3	$4.85M	Sell	64,068 -50	-0.1%	-$3.43K	0.61%	38
2019 Q2	$4.66M	Sell	64,118 -183	-0.3%	-$14.4K	0.61%	37
2019 Q1	$5.18M	Sell	64,301 -6,555	-9%	-$536K	0.7%	35
2018 Q4	$6.53M	Hold	70,856	–	–	1.01%	31
2018 Q3	$6.7M	Sell	70,856 -2	-0%	-$190	0.9%	31
2018 Q2	$6.57M	Sell	70,858 -25	-0%	-$2.44K	0.97%	33
2018 Q1	$6.71M	Sell	70,883 -500	-0.7%	-$54.9K	1.04%	32
2017 Q4	$6.9M	Sell	71,383 -658	-0.9%	-$62K	1.08%	31
2017 Q3	$6.4M	Sell	72,041 -1,000	-1%	-$76.1K	1.06%	31
2017 Q2	$5.3M	Hold	73,041	–	–	0.91%	35
2017 Q1	$4.76M	Hold	73,041	–	–	0.82%	37
2016 Q4	$4.57M	Sell	73,041 -147	-0.2%	-$8.97K	0.83%	36
2016 Q3	$4.62M	Buy	73,188 +122	+0.2%	+$7.9K	0.85%	37
2016 Q2	$4.52M	Buy	73,066 +100	+0.1%	+$6.09K	0.84%	41
2016 Q1	$4.17M	Buy	72,966 +65,670	+900%	+$3.66M	0.77%	39
2015 Q4	$4.32K	Sell	7,296 -65,470	-90%	-$3.77M	0.81%	38
2015 Q3	$3.96M	Buy	72,766 +350	+0.5%	+$22.8K	0.78%	38
2015 Q2	$4.87M	Buy	72,416 +1,750	+2%	+$114K	0.92%	36
2015 Q1	$4.14M	Hold	70,666	–	–	0.78%	39
2014 Q4	$4.62M	Hold	70,666	–	–	0.88%	35
2014 Q3	$4.08M	Hold	70,666	–	–	0.82%	42
2014 Q2	$3.99M	Hold	70,666	–	–	0.8%	42
2014 Q1	$3.63M	Hold	70,666	–	–	0.76%	44
2013 Q4	$3.73M	Hold	70,666	–	–	0.79%	42
2013 Q3	$3.16M	Buy	70,666 +300	+0.4%	+$13.3K	0.72%	44
2013 Q2	$2.91M	Buy	+70,366	New	+$3.08M	0.71%	43

Other funds holding ABBV

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mogy Joel R Investment Counsel's ABBV Position: Q2 2026 in Review

Mogy Joel R Investment Counsel reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $242K and leaving 41,919 shares worth $10.5M. The position accounts for 0.6% of the portfolio, ranked #27.

Mogy Joel R Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.6M in Q3 2025. 2,625 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mogy Joel R Investment Counsel held 41,919 shares of AbbVie worth $10.5M as of Q2 2026.
Mogy Joel R Investment Counsel sold 1,125 AbbVie shares in Q2 2026, an estimated $242K.
AbbVie made up 0.6% of Mogy Joel R Investment Counsel's portfolio in Q2 2026, its #27 holding.
Mogy Joel R Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Mogy Joel R Investment Counsel's AbbVie position peaked at $10.6M in Q3 2025.
2,625 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mogy Joel R Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.